Foundational Skills in Life Sciences

57. How to read the main points of Introduction paragraphs

19 min · 6 de jul de 2025
Portada del episodio 57. How to read the main points of Introduction paragraphs

Descripción

The Introduction section of a life-science paper tells the main story, sometimes even multiple related ones. But without helpful subheadings, understanding its core points can be challenging. Then, how do we effectively read Introduction paragraphs to understand the section?     We will talk about it today, and we will keep reading one of the best papers as our example.    We are reading the paper written by Dr. Katalin Karikó & Dr. Drew Weissman, that led to the Nobel Prize in Physiology or Medicine 2023. We call it the Milestone Article 1. Here are two sets of links related to the paper.   Milestone Article 1:  - “Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA” by Karikó, Buckstein, Ni & Weissman. Immunity, 23(2): 165-75, 2005. - HTML: https://doi.org/10.1016/j.immuni.2005.06.008 [https://doi.org/10.1016/j.immuni.2005.06.008]    - PDF: https://www.cell.com/immunity/pdf/S1074-7613(05)00211-6.pdf [https://www.cell.com/immunity/pdf/S1074-7613(05)00211-6.pdf]    - PubMed: https://pubmed.ncbi.nlm.nih.gov/16111635/ [https://pubmed.ncbi.nlm.nih.gov/16111635/]     Copyright of the paper (as of July, 2025): - See the pull-down menu “Article Info” near the top of the article webpage (Use the DOI above to reach it). - Check the “User License” section which lists the “Elsevier user license”: --- http://www.elsevier.com/open-access/userlicense/1.0/ [http://www.elsevier.com/open-access/userlicense/1.0/]    --- https://www.elsevier.com/about/policies-and-standards/open-access-licenses/elsevier-user [https://www.elsevier.com/about/policies-and-standards/open-access-licenses/elsevier-user]    This episode = mini-series: reading-37.    (My email is active. But my website is under construction. Please wait for a while. Thank you for the patience!)

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de Foundational Skills in Life Sciences!

Prueba gratis

Empieza 7 días de prueba

$99 / mes después de la prueba. · Cancela cuando quieras.

  • Podcasts solo en Podimo
  • 20 horas de audiolibros al mes
  • Podcast gratuitos

Todos los episodios

61 episodios

episode 58. Paragraph 1 of Introduction, written by Nobel Laureates: meaning of each sentence therein artwork

58. Paragraph 1 of Introduction, written by Nobel Laureates: meaning of each sentence therein

Let’s read the first paragraph of the Introduction section in a paper written by the Nobel Laureates. Specifically, we will read each sentence in the paragraph, and think about the meaning and the role of each sentence. One key point is that the structural components of the Abstract will help us understand the paragraphs and sentences of the Introduction.    We are reading the paper written by Dr. Katalin Karikó & Dr. Drew Weissman, that led to the Nobel Prize in Physiology or Medicine 2023. We call it the Milestone Article 1. Here are two sets of links related to the paper.   Milestone Article 1:  - “Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA” by Karikó, Buckstein, Ni & Weissman. Immunity, 23(2): 165-75, 2005. - HTML: https://doi.org/10.1016/j.immuni.2005.06.008 [https://doi.org/10.1016/j.immuni.2005.06.008]    - PDF: https://www.cell.com/immunity/pdf/S1074-7613(05)00211-6.pdf [https://www.cell.com/immunity/pdf/S1074-7613(05)00211-6.pdf]    - PubMed: https://pubmed.ncbi.nlm.nih.gov/16111635/ [https://pubmed.ncbi.nlm.nih.gov/16111635/]     Copyright of the paper (as of July, 2025): - See the pull-down menu “Article Info” near the top of the article webpage (Use the DOI above to reach it). - Check the “User License” section which lists the “Elsevier user license”: --- http://www.elsevier.com/open-access/userlicense/1.0/ [http://www.elsevier.com/open-access/userlicense/1.0/]    --- https://www.elsevier.com/about/policies-and-standards/open-access-licenses/elsevier-user [https://www.elsevier.com/about/policies-and-standards/open-access-licenses/elsevier-user]    This episode = mini-series: reading-38.    (My email is active. But my website is under construction. Please wait for a while. Thank you for the patience!)

13 de jul de 202516 min
episode 57. How to read the main points of Introduction paragraphs artwork

57. How to read the main points of Introduction paragraphs

The Introduction section of a life-science paper tells the main story, sometimes even multiple related ones. But without helpful subheadings, understanding its core points can be challenging. Then, how do we effectively read Introduction paragraphs to understand the section?     We will talk about it today, and we will keep reading one of the best papers as our example.    We are reading the paper written by Dr. Katalin Karikó & Dr. Drew Weissman, that led to the Nobel Prize in Physiology or Medicine 2023. We call it the Milestone Article 1. Here are two sets of links related to the paper.   Milestone Article 1:  - “Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA” by Karikó, Buckstein, Ni & Weissman. Immunity, 23(2): 165-75, 2005. - HTML: https://doi.org/10.1016/j.immuni.2005.06.008 [https://doi.org/10.1016/j.immuni.2005.06.008]    - PDF: https://www.cell.com/immunity/pdf/S1074-7613(05)00211-6.pdf [https://www.cell.com/immunity/pdf/S1074-7613(05)00211-6.pdf]    - PubMed: https://pubmed.ncbi.nlm.nih.gov/16111635/ [https://pubmed.ncbi.nlm.nih.gov/16111635/]     Copyright of the paper (as of July, 2025): - See the pull-down menu “Article Info” near the top of the article webpage (Use the DOI above to reach it). - Check the “User License” section which lists the “Elsevier user license”: --- http://www.elsevier.com/open-access/userlicense/1.0/ [http://www.elsevier.com/open-access/userlicense/1.0/]    --- https://www.elsevier.com/about/policies-and-standards/open-access-licenses/elsevier-user [https://www.elsevier.com/about/policies-and-standards/open-access-licenses/elsevier-user]    This episode = mini-series: reading-37.    (My email is active. But my website is under construction. Please wait for a while. Thank you for the patience!)

6 de jul de 202519 min